Search

Displaying results 2871 - 2880 of 10000 in total
  1. Indication

    Locally advanced Non-Small Cell Lung Carcinoma (NSCLC)

    go.drugbank.com/conditions/DBCOND0145709
    Drugs: Nintedanib
    Synonyms: Locally advanced Non-Small Cell Lung Carcinoma (NSCLC)
  2. Indication

    Locally advanced nonsquamous non-small cell lung cancer

    go.drugbank.com/conditions/DBCOND0022054
    Drugs: Bevacizumab · Pemetrexed · Sevabertinib · Telisotuzumab vedotin
    Synonyms: Locally advanced Non-Squamous Non-Small Cell Lung Cancer, Locally advanced Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
  3. Indication

    Locally advanced untreated non small cell lung cancer

    go.drugbank.com/conditions/DBCOND0025494
    Drugs: Docetaxel
    Synonyms: Locally advanced untreated non small cell lung cancer, Locally advanced Untreated Non-Small Cell Lung Cancer
  4. Indication

    Non-purulent ophthalmic infections caused by susceptible bacteria

    go.drugbank.com/conditions/DBCOND0135837
    Drugs: Chloramphenicol
    Synonyms: Non-purulent ophthalmic infections caused by susceptible bacteria
  5. Indication

    Stage 2 Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0173420
    Drugs: Pembrolizumab
    Synonyms: Stage 2 Non-Small Cell Lung Cancer (NSCLC)
  6. Drug

    Vepdegestrant

    go.drugbank.com/drugs/DB19006
    ApprovedInvestigational

    [A275508, A275509] On May 1, 2026, the FDA granted approval for vepdegestrant tablets under the trade name VEPPANU.

  7. Drug

    Vatalanib

    go.drugbank.com/drugs/DB04879
    Investigational

    Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors.

  8. Drug

    Cabazitaxel

    go.drugbank.com/drugs/DB06772
    ApprovedInvestigational

    It was first approved by the FDA on June 17, 2010.[A260421] It was also approved by the EMA on March 17, 2011 [L47381] and Health Canada on December 17, 2019.[L47376] … [A7056] Due to its low affinity for the P-glycoprotein (P-gp) efflux pump, cabazitaxel can more readily penetrate the blood–brain barrier compared to other taxanes like [paclitaxel] and [docetaxel].

  9. Drug

    Human Menstrual Blood-derived Stem Cells

    go.drugbank.com/drugs/DB15738
    Investigational

    ESCs are from the inner cell mass of blastocysts while ASCs are deposited into adult tissues with restricted differentiation potency but also a lack of tumorigenicity. … Because this is a non-invasive way to obtain stem cells, it is simple and easy to obtain the stem cells with an absence of ethical issues that may come from obtaining stem cells of the embryonic kind.

  10. Drug

    Glatiramer

    go.drugbank.com/drugs/DB05259
    ApprovedInvestigational

    [A248880] It was approved by the FDA in 1996, and a generic version became available in 2017. … Glatiramer acetate exhibits several immunomodulatory effects and reduces the relapse rate of relapsing-remitting multiple sclerosis (RRMS) by 30%.